PMID- 30191441 OWN - NLM STAT- MEDLINE DCOM- 20190529 LR - 20200309 IS - 1559-0100 (Electronic) IS - 1355-008X (Print) IS - 1355-008X (Linking) VI - 63 IP - 1 DP - 2019 Jan TI - Oral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men. PG - 149-156 LID - 10.1007/s12020-018-1741-y [doi] AB - PURPOSE: Precise evaluation of serum testosterone levels is important in making an accurate diagnosis of androgen deficiency. Recent practice guidelines on male androgen deficiency recommend that testosterone be measured in the morning while fasting. Although there is ample evidence regarding morning measurement of testosterone, studies that evaluated the effect of glucose load or meals were limited by inclusion of hypogonadal or diabetic men, and measurement of testosterone was not performed using mass spectrometry. METHODS: Sixty men (23-97 years) without pre-diabetes or diabetes who had normal total testosterone (TT) levels underwent either an oral glucose tolerance test (OGTT) or a mixed meal tolerance test (MMTT) after an overnight fast. Serum samples were collected before and at regular intervals for 2 h (OGTT cohort) or 3 h (MMTT cohort). TT was measured by LC-MS/MS. LH and prolactin were also measured. RESULTS: TT decreased after a glucose load (mean drop at nadir = 100 ng/dL) and after a mixed meal (drop at nadir = 123 ng/dL). Approximately 11% of men undergoing OGTT and 56% undergoing MMTT experienced a transient decrease in TT below 300 ng/dL, the lower normal limit. Testosterone started declining 20 min into the tests, with average maximum decline at 60 min. Most men still had TT lower than baseline at 120 min. This effect was independent of changes in LH or prolactin. CONCLUSION: A glucose load or a mixed meal transiently, but significantly, lowers TT levels in healthy, non-diabetic eugonadal men. These findings support the recommendations that measurement of serum testosterone to diagnose androgen deficiency should be performed while fasting. FAU - Gagliano-Juca, Thiago AU - Gagliano-Juca T AUID- ORCID: 0000-0002-2960-1059 AD - Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. tgagliano@partners.org. FAU - Li, Zhuoying AU - Li Z AD - Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. FAU - Pencina, Karol M AU - Pencina KM AD - Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. FAU - Beleva, Yusnie M AU - Beleva YM AD - Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. FAU - Carlson, Olga D AU - Carlson OD AD - Laboratory of Clinical Investigation, National Institute on Aging, Baltimore, MD, 21225, USA. FAU - Egan, Josephine M AU - Egan JM AD - Laboratory of Clinical Investigation, National Institute on Aging, Baltimore, MD, 21225, USA. FAU - Basaria, Shehzad AU - Basaria S AD - Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. LA - eng GR - Z99 AG999999/Intramural NIH HHS/United States GR - 03-AG-N035/AG/NIA NIH HHS/United States GR - 15-AG-N074/AG/NIA NIH HHS/United States PT - Journal Article DEP - 20180906 PL - United States TA - Endocrine JT - Endocrine JID - 9434444 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 3XMK78S47O (Testosterone) RN - 9002-62-4 (Prolactin) RN - 9002-67-9 (Luteinizing Hormone) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Adult MH - Blood Glucose/analysis MH - Cohort Studies MH - Glucose/*pharmacology MH - Glucose Tolerance Test MH - *Glycemic Load MH - Healthy Volunteers MH - Humans MH - Insulin/blood MH - Longitudinal Studies MH - Luteinizing Hormone/blood MH - Male MH - *Meals MH - Middle Aged MH - Prolactin/blood MH - Testosterone/*blood MH - Young Adult PMC - PMC6445266 MID - NIHMS1010918 OTO - NOTNLM OT - Hypogonadism OT - LH OT - Mixed meal tolerance test OT - Oral glucose tolerance test OT - Sex hormones OT - Testosterone COIS- Compliance with ethical standards Conflict of interest Dr. Basaria has no conflict of interest related to the current work. He has previously received grant support from Abbott Pharmaceuticals for investigator-initiated studies unrelated to this study and has previously consulted for AbbVie, Eli Lilly, Inc and Regeneron Pharmaceuticals. The other authors declare that they have no conflict of interest. EDAT- 2018/09/08 06:00 MHDA- 2019/05/30 06:00 PMCR- 2019/04/02 CRDT- 2018/09/08 06:00 PHST- 2018/07/18 00:00 [received] PHST- 2018/08/29 00:00 [accepted] PHST- 2018/09/08 06:00 [pubmed] PHST- 2019/05/30 06:00 [medline] PHST- 2018/09/08 06:00 [entrez] PHST- 2019/04/02 00:00 [pmc-release] AID - 10.1007/s12020-018-1741-y [pii] AID - 10.1007/s12020-018-1741-y [doi] PST - ppublish SO - Endocrine. 2019 Jan;63(1):149-156. doi: 10.1007/s12020-018-1741-y. Epub 2018 Sep 6.